These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 1453047

  • 1. [Usefulness of intraperitoneal carboplatin administration-- pharmacokinetic analysis].
    Ito K, Itani Y, Furuki K, Tamori N, Noda T, Adachi S, Hirano Y, Kato Y, Kiyozuka Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1180-6. PubMed ID: 1453047
    [Abstract] [Full Text] [Related]

  • 2. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].
    Fujiwara K, Yamauchi H, Sawada S, Koike H, Mohri H, Ohishi Y, Kohno I.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2373-9. PubMed ID: 1463344
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer].
    Ohno M, Hirokawa M, Hando T.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342
    [Abstract] [Full Text] [Related]

  • 4. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y, Fujiwara K, Kigawa J, Itamochi H, Nagao S, Aotani E, Terakawa N, Kohno I, Sankai Gynecology Study Group (SGSG).
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [Abstract] [Full Text] [Related]

  • 5. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
    [Abstract] [Full Text] [Related]

  • 6. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
    Shimizu A, Kimura T, Funatsu M, Hada Y, Tamura K, Taguchi A, Miyakawa Z, Notake Y.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
    [Abstract] [Full Text] [Related]

  • 7. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B, Delroeux D, Guardiola E, Combe M, Hoizey G, Montange D, Kantelip JP, Chauffert B, Heyd B, Pivot X.
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [Abstract] [Full Text] [Related]

  • 8. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
    Shimizu A, Kimura T, Funatsu M, Hada Y, Araki H, Notake Y.
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
    [Abstract] [Full Text] [Related]

  • 9. [Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis].
    Mizuno I, Yasui T, Takeyama H, Ishikawa M, Terada J, Mohri N, Ueda T, Sumita N, Kobayashi K, Akamo Y.
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1598-601. PubMed ID: 7574769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
    Shen M, Schilder RJ, Obasaju C, Gallo JM.
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):243-50. PubMed ID: 12203107
    [Abstract] [Full Text] [Related]

  • 19. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
    Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA.
    Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
    Noda T, Oku M, Kiyozuka Y, Maruyama M, Adachi S, Akada S, Okamura Y, Ichijo M.
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2929-35. PubMed ID: 3178241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.